Covid: The world turns to China for vaccines after India, US stumble
Top Searches
Covid: The world turns to China for vaccines after India, US stumble
Bloomberg / Updated: May 7, 2021, 21:35 IST
FacebookTwitterLinkedinEMail
China’s reliability as a vaccine supplier is increasing its geopolitical clout at a time when the US and the EU have been slow confronting the global pandemic as Covid hot spots rage out of control in India, Brazil and elsewhere.
BEIJING: The world is fast becoming ever more reliant on China for vaccines, with India’s raging virus outbreak stifling its ability to deliver on supply deals, even as the US tries to position itself as a champion of wider access.
Why the world is turning to China for vaccines
07 May 2021 People queue up for a Chinese Sinopharm COVID-19 vaccine at the Boris Trajkovski Arena in Skopje, Macedonia, on Thursday. Agence France-Presse
Iain Marlow, Sudhi Ranjan Sen and James Paton,
Tribune News Service
The world is fast becoming ever more reliant on China for vaccines, with India’s raging virus outbreak stifling its ability to deliver on supply deals, even as the US tries to position itself as a champion of wider access.
Over the past few weeks, leaders of some of the globe’s most populous nations have sought more shots from China despite concerns about their effectiveness. Demand is expected to rise even further if the World Health Organisation, as expected, authorises vaccines from China’s Sinovac Biotech Ltd. and Sinopharm Group Co. Ltd., allowing developing countries in Asia, Africa and Latin America to access them through Covax, the global vaccination effort.
A New Wave of Vaccines Is Coming, and Theyâre Not All Also-Rans
May 06 2021, 1:44 PM
May 06 2021, 9:31 AM
May 06 2021, 1:44 PM
(Bloomberg Businessweek) The Covid-19 vaccine rollout has given drugmakers the kind of brand-name shorthand usually reserved for more mundane consumer products: People talk about getting Pfizer, Moderna, J&J, or Astra much as they might reach for a Kleenex or a Popsicle. And those companies have contracts to provide billions of doses, appearing to leave little room for other entrants. So why are dozens of hopefuls still working .
(Bloomberg Businessweek) The Covid-19 vaccine rollout has given drugmakers the kind of brand-name shorthand usually reserved for more mundane consumer products: People talk about getting Pfizer, Moderna, J&J, or Astra much as they might reach for a Kleenex or a Popsicle. And those companies have contracts to provide billions of doses, appearing to leave little room for other entrants. So why are dozens of hopefuls s
Europe Has Finally Turned a Corner on Covid-19 Vaccinations
Bloomberg 2 hrs ago Tim Loh
(Bloomberg) The European Union’s long-awaited Covid-19 shot surge is finally here, raising hopes the continent can bring the pandemic under control and reopen economies faster than expected.
Popular Searches
The inflection point came this month, with Germany nearly doubling the pace of vaccinations after an increase in supplies and the decision to let general practitioners administer doses in their regular offices. France, Italy and Spain are following a similar trajectory.
The bloc has had to overcome multiple hurdles, including delays to vaccine deliveries from AstraZeneca Plc and health concerns because of a blood clot risk associated with some shots. Earlier this month, Johnson & Johnson halted deliveries of its vaccine, but reversed course on Tuesday after the EU’s drug regulator said the benefits outweigh the risks.
Thailand Set to Ban Booze, J&J Halt May Last Weeks: Virus Update
Bloomberg 2 hrs ago Bloomberg News
(Bloomberg) Thailand is preparing to shut schools and ban the sale of alcoholic beverages to stem a fresh outbreak that’s threatening the revival of one of the world’s most popular tourist destinations.
Popular Searches
Elsewhere in Asia, a senior official in Japan’s ruling party indicated the Tokyo Olympics may be canceled as the country struggles with a surge in coronavirus cases less than 100 days before the Games are due to begin. Hong Kong and Singapore could start their long-awaited travel bubble as soon as mid-May, the South China Morning Post reported. But obstacles remain opening up a quarantine-free corridor between the two Asian financial hubs.